1
van Maaren, Marissa C., de Munck, Linda, Strobbe, Luc J. A., Sonke, Gabe S., Westenend, Pieter J., Smidt, Marjolein L., Poortmans, Philip M. P., Siesling, Sabine
Veröffentlicht in: van Maaren , M C , de Munck , L , Strobbe , L J A , Sonke , G S , Westenend , P J , Smidt , M L , Poortmans , P M P & Siesling , S 2019 , ' Ten-year recurrence rates for breast cancer subtypes in the Netherlands : A large population-based study ' , International Journal of Cancer , vol. 144 , no. 2 , pp. 263-272 . https://doi.org/10.1002/ijc.31914;
2019
Veröffentlicht in: van Maaren , M C , de Munck , L , Strobbe , L J A , Sonke , G S , Westenend , P J , Smidt , M L , Poortmans , P M P & Siesling , S 2019 , ' Ten-year recurrence rates for breast cancer subtypes in the Netherlands : A large population-based study ' , International Journal of Cancer , vol. 144 , no. 2 , pp. 263-272 . https://doi.org/10.1002/ijc.31914;
2019
2
3
de Wild, Sabine R., de Munck, Linda, Simons, Janine M., Verloop, Janneke, van Dalen, Thijs, Elkhuizen, Paula H.M., Houben, Ruud M.A., van Leeuwen, A. Elise, Linn, Sabine C., Pijnappel, Ruud M., Poortmans, Philip M.P., Strobbe, Luc J.A., Wesseling, Jelle, Voogd, Adri C., Boersma, Liesbeth J.
Veröffentlicht in: de Wild , S R , de Munck , L , Simons , J M , Verloop , J , van Dalen , T , Elkhuizen , P H M , Houben , R M A , van Leeuwen , A E , Linn , S C , Pijnappel , R M , Poortmans , P M P , Strobbe , L J A , Wesseling , J , Voogd , A C & Boersma , L J 2022 , ' De-escalation of radiotherapy after primary chemotherapy in cT1–2N1 breast cancer (RAPCHEM; BOOG 2010–03) : 5-year follow-up results of a Dutch, prospective, registry study ' , The Lancet Oncology , vol. 23 , no. 9 , pp. 1201-1210 . https://doi.org/10.1016/S1470-2045(22)00482-X;
2022
Veröffentlicht in: de Wild , S R , de Munck , L , Simons , J M , Verloop , J , van Dalen , T , Elkhuizen , P H M , Houben , R M A , van Leeuwen , A E , Linn , S C , Pijnappel , R M , Poortmans , P M P , Strobbe , L J A , Wesseling , J , Voogd , A C & Boersma , L J 2022 , ' De-escalation of radiotherapy after primary chemotherapy in cT1–2N1 breast cancer (RAPCHEM; BOOG 2010–03) : 5-year follow-up results of a Dutch, prospective, registry study ' , The Lancet Oncology , vol. 23 , no. 9 , pp. 1201-1210 . https://doi.org/10.1016/S1470-2045(22)00482-X;
2022
4
de Wild, Sabine R, de Munck, Linda, Simons, Janine M, Verloop, Janneke, van Dalen, Thijs, Elkhuizen, Paula H M, Houben, Ruud M A, van Leeuwen, A Elise, Linn, Sabine C, Pijnappel, Ruud M, Poortmans, Philip M P, Strobbe, Luc J A, Wesseling, Jelle, Voogd, Adri C, Boersma, Liesbeth J
Veröffentlicht in: de Wild , S R , de Munck , L , Simons , J M , Verloop , J , van Dalen , T , Elkhuizen , P H M , Houben , R M A , van Leeuwen , A E , Linn , S C , Pijnappel , R M , Poortmans , P M P , Strobbe , L J A , Wesseling , J , Voogd , A C & Boersma , L J 2022 , ' De-escalation of radiotherapy after primary chemotherapy in cT1-2N1 breast cancer (RAPCHEM; BOOG 2010-03) : 5-year follow-up results of a Dutch, prospective, registry study ' , Lancet oncology , vol. 23 , no. 9 , pp. 1201-1210 . https://doi.org/10.1016/S1470-2045(22)00482-X;
2022
Veröffentlicht in: de Wild , S R , de Munck , L , Simons , J M , Verloop , J , van Dalen , T , Elkhuizen , P H M , Houben , R M A , van Leeuwen , A E , Linn , S C , Pijnappel , R M , Poortmans , P M P , Strobbe , L J A , Wesseling , J , Voogd , A C & Boersma , L J 2022 , ' De-escalation of radiotherapy after primary chemotherapy in cT1-2N1 breast cancer (RAPCHEM; BOOG 2010-03) : 5-year follow-up results of a Dutch, prospective, registry study ' , Lancet oncology , vol. 23 , no. 9 , pp. 1201-1210 . https://doi.org/10.1016/S1470-2045(22)00482-X;
2022